JPRN-UMIN000023200已完成4 期
The study of Intravitreal aflibercept with treat and extend regimen for macular edema with branch retinal vein occlusion (BRVO) - The study of aflibercept with treat and extend regimen for BRVO
Department of Ophthalmology, Akita University0 个研究点目标入组 50 人开始时间: 2016年9月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1. History of vitrectomy or glaucoma surgery 2. Other disorders such as DME, CRVO or idiopathic macular telangiectasia 3. Poor control hypertension (systolic pressure >180mmHg, diastolic pressure >100mmHg) 4. Concomitant conditions/diseases including uncontrolled glaucoma and intraocular inflammation 5. Patients who the doctor in charge judges are ineligible for the study
研究者
相似试验
已完成
3 期
The efficacy of intravitreal aflibercept given in a ‘treat and extend’ regime in the treatment of cystoid macular oedema secondary to central retinal vein occlusion.central retinal vein occlusion (CRVO).cystoid macular oedemaEye - Diseases / disorders of the eyeACTRN12615000417583Centre for Eye Research Australia20
已完成
不适用
Efficacy evaluation of intravitreal aflibercept for polypoidal choroidal vasculopathyJPRN-UMIN000010461Yokohama City University Medical Center30
进行中(未招募)
不适用
Optical Coherence Tomography Angiography Biomarkers in a Bi-monthly Maintenance Dosing Aflibercept in Patients with Neovascular Age-Related Macular DegeneratioDiseases of the eye and adnexaKCT0007375Kyung Hee University Hospital40
已完成
不适用
Effect of Intravitreal Aflibercept Injection on Microaneurysm in Patients with Diabetic Macular EdemaJPRN-UMIN000018315Department of Ophthalmology, Mie University30
进行中(未招募)
1 期
The Effect of Intravitreal Aflibercept on Ocular Perfusion – a Pilot StudyExudative AMDMedDRA version: 19.1Level: LLTClassification code 10025411Term: Macular degeneration senileSystem Organ Class: 100000004853EUCTR2016-004608-78-ATKepler University Hospital, Institute of Ophthalmology
